Kanoria Chemicals & Industries Limited
Kanoria Chemicals & Industries Limited (KANORICHEM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Industrials›Capital Goods›Industrial Manufacturing›Industrial Products
kanoriachem.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 371 Cr | 342 Cr | 362 Cr | 384 Cr | 374 Cr | 348 Cr | 431 Cr | 454 Cr | 210 Cr | 266 Cr | 304 Cr | 460 Cr |
| Operating expenses (approx.) | 365 Cr | 339 Cr | 333 Cr | 382 Cr | 361 Cr | 348 Cr | 414 Cr | 437 Cr | 204 Cr | 246 Cr | 277 Cr | 415 Cr |
| EBITDA | 6 Cr | 3 Cr | 29 Cr | 2 Cr | 13 Cr | -0.44 Cr | 17 Cr | 16 Cr | 6 Cr | 20 Cr | 27 Cr | 45 Cr |
| OPM % | 1.6% | 0.8% | 8.0% | 0.5% | 3.5% | -0.1% | 3.9% | 3.6% | 3.0% | 7.5% | 8.9% | 9.8% |
| Other income | -0.69 Cr | 8 Cr | 0.54 Cr | 1 Cr | 5 Cr | 0.71 Cr | 3 Cr | 0.76 Cr | 12 Cr | 2 Cr | 7 Cr | 7 Cr |
| Interest | 12 Cr | 9 Cr | 12 Cr | 11 Cr | 12 Cr | 11 Cr | 12 Cr | 11 Cr | 9 Cr | 8 Cr | 8 Cr | 7 Cr |
| Depreciation | 15 Cr | 16 Cr | 16 Cr | 15 Cr | 15 Cr | 16 Cr | 16 Cr | 17 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr |
| Profit before tax | -21 Cr | -14 Cr | 2 Cr | -20 Cr | -9 Cr | -27 Cr | -38 Cr | -10 Cr | 95 Cr | 6 Cr | 17 Cr | 35 Cr |
| Tax % | 2.8% | -11.8% | 861.7% | -4.8% | -75.7% | -6.4% | -5.3% | -31.7% | 3.6% | 38.0% | -86.0% | 25.2% |
| Net profit | -21 Cr | -15 Cr | -16 Cr | -23 Cr | -16 Cr | -29 Cr | -40 Cr | -14 Cr | 92 Cr | 4 Cr | 32 Cr | 26 Cr |
| EPS (₹) | ₹-4.20 | ₹-1.86 | ₹-2.12 | ₹-3.81 | ₹-3.18 | ₹-3.82 | ₹-8.33 | ₹-1.79 | ₹21.38 | ₹0.81 | ₹7.24 | ₹6.03 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,074 Cr | 1,005 Cr | 1,095 Cr | 1,369 Cr | 1,578 Cr | 1,477 Cr | 1,537 Cr | 981 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,010 Cr | 977 Cr | 1,001 Cr | 1,301 Cr | 1,506 Cr | 1,424 Cr | 1,505 Cr | 910 Cr | Sign in for TTM |
| EBITDA | 64 Cr | 28 Cr | 94 Cr | 68 Cr | 72 Cr | 53 Cr | 31 Cr | 71 Cr | Sign in for TTM |
| OPM % | 5.9% | 2.8% | 8.6% | 5.0% | 4.6% | 3.6% | 2.0% | 7.3% | Sign in for TTM |
| Other income | 12 Cr | 22 Cr | 12 Cr | 29 Cr | 10 Cr | 19 Cr | 9 Cr | 22 Cr | Sign in for TTM |
| Interest | 36 Cr | 37 Cr | 32 Cr | 27 Cr | 36 Cr | 43 Cr | 46 Cr | 32 Cr | Sign in for TTM |
| Depreciation | 49 Cr | 56 Cr | 58 Cr | 57 Cr | 59 Cr | 63 Cr | 63 Cr | 35 Cr | Sign in for TTM |
| Profit before tax | -15 Cr | -43 Cr | 11 Cr | 13 Cr | -12 Cr | -36 Cr | -95 Cr | 107 Cr | Sign in for TTM |
| Tax % | -30.2% | 26.3% | -39.9% | 83.0% | -5.5% | -53.7% | -12.5% | -5.3% | Sign in for TTM |
| Net profit | -19 Cr | -32 Cr | 16 Cr | 2 Cr | -13 Cr | -55 Cr | -108 Cr | 113 Cr | Sign in for TTM |
| EPS (₹) | ₹-3.42 | ₹-5.90 | ₹3.32 | ₹1.56 | ₹-2.01 | ₹-8.79 | ₹-19.13 | ₹27.64 | Sign in for TTM |
| Dividend payout % | — | — | — | 0.0% | — | — | — | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 22 Cr | 22 Cr | 22 Cr | 22 Cr | 22 Cr | 22 Cr | 22 Cr | 22 Cr |
| Reserves | 577 Cr | 547 Cr | 565 Cr | 576 Cr | 584 Cr | 579 Cr | 499 Cr | 551 Cr |
| Borrowings | 455 Cr | — | — | — | 508 Cr | 507 Cr | 594 Cr | 290 Cr |
| Other liabilities | 331 Cr | 805 Cr | 775 Cr | 805 Cr | 367 Cr | 366 Cr | 394 Cr | 254 Cr |
| Total liabilities | 1,401 Cr | 1,374 Cr | 1,362 Cr | 1,403 Cr | 1,481 Cr | 1,490 Cr | 1,498 Cr | 1,117 Cr |
| Fixed assets (net) | 806 Cr | — | — | — | 843 Cr | 811 Cr | 855 Cr | 727 Cr |
| CWIP | 42 Cr | — | — | — | 10 Cr | 46 Cr | 44 Cr | 32 Cr |
| Investments | 48 Cr | — | — | — | 17 Cr | 16 Cr | 14 Cr | 59 Cr |
| Loans & advances | 0.25 Cr | — | — | — | 0.39 Cr | 0.23 Cr | 0.37 Cr | 0.50 Cr |
| Inventories | 190 Cr | — | — | — | 278 Cr | 285 Cr | 246 Cr | 106 Cr |
| Trade receivables | 146 Cr | — | — | — | 196 Cr | 186 Cr | 238 Cr | 134 Cr |
| Cash & bank | 19 Cr | — | — | — | 19 Cr | 11 Cr | 8 Cr | 10 Cr |
| Other assets | 149 Cr | 1,374 Cr | 1,362 Cr | 1,403 Cr | 119 Cr | 135 Cr | 93 Cr | 49 Cr |
| Total assets | 1,401 Cr | 1,374 Cr | 1,362 Cr | 1,403 Cr | 1,481 Cr | 1,490 Cr | 1,498 Cr | 1,117 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 83 Cr | 26 Cr | 38 Cr | 20 Cr | 66 Cr |
| Cash from investing | — | — | — | -43 Cr | -25 Cr | -50 Cr | -65 Cr | -39 Cr |
| Cash from financing | — | — | — | -53 Cr | -0.77 Cr | 5 Cr | 41 Cr | -25 Cr |
| Net cash flow | — | — | — | -13 Cr | -0.02 Cr | -8 Cr | -3 Cr | 2 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 40 Cr | -32 Cr | -43 Cr | -80 Cr | -22 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 2.0% | -1.1% | 7.5% | 6.7% | 2.1% | 0.6% | -4.4% | 16.2% |
| ROE % | -2.5% | -4.8% | 2.6% | 1.2% | 1.4% | -5.4% | -14.7% | 26.4% |
| Debtor days | 49 | — | — | — | 45 | 46 | 56 | 50 |
| Inventory days | 94 | — | — | — | 88 | 105 | 85 | 64 |
| Days payable | 73 | — | — | — | 73 | 83 | 79 | 82 |
| Cash conversion cycle | 71 | — | — | — | 60 | 69 | 63 | 32 |
| Debt / equity | 0.76 | — | — | — | 0.84 | 0.84 | 1.16 | 0.51 |
| Current ratio | 1.11 | — | — | — | 1.12 | 1.11 | 0.99 | 0.92 |
| Net debt / EBITDA | 6.84 | 0.00 | 0.00 | 0.00 | 6.75 | 9.40 | 18.68 | 3.92 |
Compare with peers
Loading peers…